グリコスフィンゴリピド合成は,KRAS誘発がんにおける免疫回避を媒介する
Mariluz Soula1, Gokhan Unlu1, Rachel Welch1
1Laboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, NY, USA.
Nature
|August 7, 2024
まとめ
癌細胞は免疫攻撃を回避するために スフィンゴリピド合成を利用します この経路を阻害すると,抗癌免疫力が強化され,治療法と連携し,ガンに対する免疫回避の主要標的としてグリコスフィンゴリピドが明らかになります.
科学分野:
- 癌 生物学
- 免疫学
- 代謝経路
背景:
- 癌細胞は成長と適応のために脂質代謝を再プログラムします
- 腫瘍形成における特定の脂質の正確な役割は完全に理解されていません.
- 脂質代謝は膜機能,シグナル伝達,エネルギー生産に不可欠です.
研究 の 目的:
- 癌の免疫回避における de novo スフィンゴリピド合成の役割を調査する.
- 腫瘍の免疫回避メカニズムに関与する特定の脂質を特定する.
- ガン治療のためのスフィンゴリピド合成を標的とした治療戦略を探求する.
主な方法:
- 機能的ゲノミクスと脂質学的アプローチが採用された.
- 癌細胞培養とマウスモデル (シンジェニックと免疫欠乏症) で実験を行った.
- インターフェロン- ガンマ (IFNγ) 信号伝達経路を分析した.
主要な成果:
- 癌の免疫回避には新しいスフィンゴリピド合成が不可欠ですが,培養物や免疫欠乏症のマウスの増殖には必要ありません.
- スフィンゴリピド合成を阻害すると,IFNγシグナル伝達により,自然キラー (NK) とCD8+T細胞の抗腫瘍効果が強化されます.
- グライコスフィンゴリピドの減少はIFNγ受容体1 (IFNGR1) の表面レベルを上昇させ,IFNγ誘発の成長停止を媒介する.
- 薬理学的なグリコスフィンゴリピド合成抑制は,チェックポイント阻害療法と連携する.
結論:
- ガンに対する免疫回避には必要であり,制限する代謝物質である.
- de novoスフィンゴリピド合成をターゲットにすることは,抗腫瘍免疫を強化するための有望な戦略です.
- この経路は,がんの免疫回避を克服し,治療結果を改善するために重要なターゲットです.
関連する概念動画
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


